資源描述:
《中西藥合劑康婦特栓治療外陰陰道念珠菌病61例療效觀察 》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、中西藥合劑康婦特栓治療外陰陰道念珠菌病61例療效觀察【摘要】目的觀察康婦特栓治療外陰陰道念珠菌?。╲ulvovaginalcandidiasis,VVC)的實際效果。方法對我院門診確診為VVC及混合感染性陰道炎61例患者,隨機分為康婦特栓組和達克寧栓組進行比較。結(jié)果兩組第1療程后的治愈率,康婦特栓組41.94%,明顯好于達克寧栓組16.67%,P<0.05,差異有顯著性。但第2療程后及總治愈率兩組之間差異無顯著性(P>0.05)。結(jié)論中西藥合劑康婦特栓可作為治療VVC局部用藥的首選藥物。但混合感染的治愈需要相對長的療程。對支原體的治療使其轉(zhuǎn)陰有
2、一定難度,但可緩解由其造成的陰道癥狀,徹底治愈混合感染性陰道炎有賴于聯(lián)合應(yīng)用其他抗生素?!娟P(guān)鍵詞】念珠菌;支原體;炎性細(xì)胞;陰道炎;康婦特栓;達克寧栓Clinicalobservationof61patientswithvulvovaginalcandidiasisbytreatmentofconfortpessariescompound10medicamentsynthesizedbyChinesetraditionalmedicineandwesternmedicine【Abstract】ObjectiveToobservethefactualther
3、apeuticeffectofconfortpessariescompoundsuppositorysynthesizedbymedicamentChinesetraditionalmedicineandwesternmedicine.Methods61patientsinourhospitalwithvulvovaginalcandidiasiswererandomlydividedintoconfortpessariesandmiconazolegroup.Whereafter,thetherapeuticeffectofthemwerecompare
4、d.ResultsAfterthefirstperiodoftreatment,thecurerateofconfortpessarieswas41.94%,whichmarkedlyexcelledthatofmiconazolegroup(16.67%)andtherewassignificantdifferencebetweenthem(P<0.05).Buttherewasnosignificantdifferenceintotalcureratebetweenthem(P>0.05)afterthesecondperiodoftrea
5、tment.ConclusionConfortpessariescompoundsuppositorysynthesizedbymedicamentChinesetraditionalmedicineandwesternmedicinecouldbeusedasthepreferredmedicinetotreatvulvovaginalcandidiasis.Buthybridinfectionsneedlongertime.Thereweresomedifficultiesincuringtheinfectionofmycoplasma,butit10
6、couldrelievethesymptominducedbytheinfection.Soitdependedtobeassociatedwithotherantibiotictocurehybridinfectivecolpitis.【Keywords】candida;mycoplasma;colpitis;inflammatorycell;confortsuppository;miconazolesuppository陰道炎是婦科門診的常見病,隨著廣譜抗生素的廣泛應(yīng)用,性傳播疾病的增加,陰道炎尤其是外陰陰道念珠菌?。╒VC)的發(fā)病呈上升趨勢。并且混合
7、感染、復(fù)發(fā)性陰道炎的患者增多,這為臨床治療工作帶來了一定困難。因此,各種治療陰道炎的藥物應(yīng)運而生,療效不一?,F(xiàn)就中西藥合劑康婦特栓的臨床應(yīng)用效果進行分析和評價。1資料與方法101.1一般資料患者均為來自我院2004年4~7月的門診病例,根據(jù)臨床癥狀、體征及細(xì)菌學(xué)檢查,確診為單純VVC(50例)、念珠菌合并支原體(6例)、念珠菌合并炎性細(xì)胞(5例)混合感染性陰道炎,共計61例。隨機分為兩組:康婦特栓組31例,年齡24~76歲,平均42歲;達克寧栓組30例,年齡21~58歲,平均41歲。兩組發(fā)病高峰均在30~50歲之間,占78.69%。30歲<年齡<
8、;50歲的發(fā)病總計占21.31%。兩組患者的病程同樣,最短2天,最